Efficacy and tolerability of isocitrate dehydrogenase inhibitors in patients with acute myeloid leukemia: A systematic review of clinical trials-Reference-Cited by-同舟云学术

Efficacy and tolerability of isocitrate dehydrogenase inhibitors in patients with acute myeloid leukemia: A systematic review of clinical trials

Published:2023-06 Issue: Volume:129 Page:107077
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Aiman Wajeeha,Ali Muhammad Ashar^ORCID,Basit Muhammad Abdul,Omar Zainab,Suleman Muhammad,Hassan Muhammad,Jamil Taimoor,Anwar Muhammad Saad,Shafique Zubair,Dhanesar Gurneel,Faisal Muhammad Salman,Akerman Michael J.,Maroules Michael,Anwer Faiz

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference34 articles.

1. Acute myeloid leukemia.;Döhner;N. Engl. J. Med.,2015

2. Acute myeloid leukemia and myelodysplastic syndromes in older patients.;Estey;J. Clin. Oncol.,2007

3. Acute myelogenous leukemia in adolescents and young adults.;Creutzig;Pediatr. Blood Cancer,2018

4. Management of older or unfit patients with acute myeloid leukemia;Walter;Leukemia,2015

5. Genomic classification and prognosis in acute myeloid leukemia;Papaemmanuil;N. Engl. J. Med.,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MT1E in AML: a gateway to understanding regulatory cell death and immunotherapeutic responses;Journal of Leukocyte Biology;2024-06-29

2. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors;Current Treatment Options in Oncology;2024-05-02

3. Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9‐dependent AML;HemaSphere;2024-05

4. Targeted single‐cell RNA sequencing analysis reveals metabolic reprogramming and the ferroptosis‐resistant state in hematologic malignancies;Cell Biochemistry and Function;2023-10-12

5. IDH1/2 inhibitor monotherapy in blast‐phase myeloproliferative neoplasms: A multicentre experience;British Journal of Haematology;2023-08-03